Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | JAK2 |
Variant | Y613fs |
Impact List | frameshift |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | JAK2 Y613fs results in a change in the amino acid sequence of the Jak2 protein beginning at aa 613 of 1132, likely resulting in premature truncation of the functional protein (UniProt.org). Due to the loss of most of protein kinase domain 1 and all of protein kinase domain 2 (UniProt.org), Y613fs is predicted to lead to a loss of Jak2 protein function. |
Associated Drug Resistance | |
Category Variants Paths |
JAK2 mutant JAK2 inact mut JAK2 Y613fs |
Transcript | NM_004972.4 |
gDNA | chr9:g.(5073757_5073758) |
cDNA | c.(1837_1836) |
Protein | p.Y613fs |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_004972.3 | chr9:g.(5073757_5073758) | c.(1837_1836) | p.Y613fs | RefSeq | GRCh38/hg38 |
NM_001322195.2 | chr9:g.(5073757_5073758) | c.(1837_1836) | p.Y613fs | RefSeq | GRCh38/hg38 |
NM_001322196.2 | chr9:g.(5073757_5073758) | c.(1837_1836) | p.Y613fs | RefSeq | GRCh38/hg38 |
NM_001322196 | chr9:g.(5073757_5073758) | c.(1837_1836) | p.Y613fs | RefSeq | GRCh38/hg38 |
NM_004972 | chr9:g.(5073757_5073758) | c.(1837_1836) | p.Y613fs | RefSeq | GRCh38/hg38 |
NM_001322194 | chr9:g.(5073757_5073758) | c.(1837_1836) | p.Y613fs | RefSeq | GRCh38/hg38 |
NM_001322195 | chr9:g.(5073757_5073758) | c.(1837_1836) | p.Y613fs | RefSeq | GRCh38/hg38 |
NM_004972.4 | chr9:g.(5073757_5073758) | c.(1837_1836) | p.Y613fs | RefSeq | GRCh38/hg38 |
NM_001322195.1 | chr9:g.(5073757_5073758) | c.(1837_1836) | p.Y613fs | RefSeq | GRCh38/hg38 |
NM_001322194.2 | chr9:g.(5073757_5073758) | c.(1837_1836) | p.Y613fs | RefSeq | GRCh38/hg38 |
NM_001322196.1 | chr9:g.(5073757_5073758) | c.(1837_1836) | p.Y613fs | RefSeq | GRCh38/hg38 |
NM_001322194.1 | chr9:g.(5073757_5073758) | c.(1837_1836) | p.Y613fs | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|